The Health Care Select Sector SPDR Fund (XLV) and the Vanguard FTSE Europe Index Fund ETF Shares (VGK) are both among the Top 100 ETFs. XLV is a SPDR State Street Global Advisors Health fund and VGK is a Vanguard Europe Stock fund. So, what’s the difference between XLV and VGK? And which fund is better?
The expense ratio of XLV is 0.04 percentage points higher than VGK’s (0.12% vs. 0.08%). XLV also has a higher exposure to the healthcare sector and a lower standard deviation. Overall, XLV has provided higher returns than VGK over the past ten years.
In this article, we’ll compare XLV vs. VGK. We’ll look at portfolio growth and holdings, as well as at their fund composition and industry exposure. Moreover, I’ll also discuss XLV’s and VGK’s risk metrics, performance, and annual returns and examine how these affect their overall returns.
|Name||Health Care Select Sector SPDR Fund||Vanguard FTSE Europe Index Fund ETF Shares|
|Issuer||SPDR State Street Global Advisors||Vanguard|
The Health Care Select Sector SPDR Fund (XLV) is a Health fund that is issued by SPDR State Street Global Advisors. It currently has 27.88B total assets under management and has yielded an average annual return of 15.02% over the past 10 years. The fund has a dividend yield of 1.4% with an expense ratio of 0.12%.
The Vanguard FTSE Europe Index Fund ETF Shares (VGK) is a Europe Stock fund that is issued by Vanguard. It currently has 25.7B total assets under management and has yielded an average annual return of 6.68% over the past 10 years. The fund has a dividend yield of 2.52% with an expense ratio of 0.08%.
XLV’s dividend yield is 1.12% lower than that of VGK (1.4% vs. 2.52%). Also, XLV yielded on average 8.35% more per year over the past decade (15.02% vs. 6.68%). The expense ratio of XLV is 0.04 percentage points higher than VGK’s (0.12% vs. 0.08%).
The Health Care Select Sector SPDR Fund (XLV) has the most exposure to the Healthcare sector at 100.0%. This is followed by Technology and Industrials at 0.0% and 0.0% respectively. Consumer Cyclical (0.0%), Financial Services (0.0%), and Real Estate (0.0%) only make up 0.00% of the fund’s total assets.
XLV’s mid-section with moderate exposure is comprised of Consumer Defensive, Utilities, Communication Services, Energy, and Industrials stocks at 0.0%, 0.0%, 0.0%, 0.0%, and 0.0%.
The Vanguard FTSE Europe Index Fund ETF Shares (VGK) has the most exposure to the Financial Services sector at 15.85%. This is followed by Industrials and Healthcare at 15.58% and 13.76% respectively. Utilities (3.89%), Energy (4.3%), and Communication Services (5.09%) only make up 13.28% of the fund’s total assets.
VGK’s mid-section with moderate exposure is comprised of Basic Materials, Technology, Consumer Defensive, Consumer Cyclical, and Healthcare stocks at 7.67%, 8.3%, 11.39%, 11.6%, and 13.76%.
XLV is 86.24% more exposed to the Healthcare sector than VGK (100.0% vs 13.76%). XLV’s exposure to Technology and Industrials stocks is 8.30% lower and 15.58% lower respectively (0.0% vs. 8.3% and 0.0% vs. 15.58%). In total, Consumer Cyclical, Financial Services, and Real Estate also make up 30.02% less of the fund’s holdings compared to VGK (0.00% vs. 30.02%).
|Johnson & Johnson||9.19%|
|UnitedHealth Group Inc||8.01%|
|Thermo Fisher Scientific Inc||4.2%|
|Merck & Co Inc||4.17%|
|Eli Lilly and Co||3.87%|
XLV’s Top Holdings are Johnson & Johnson, UnitedHealth Group Inc, Pfizer Inc, Abbott Laboratories, and AbbVie Inc at 9.19%, 8.01%, 4.64%, 4.36%, and 4.21%.
Thermo Fisher Scientific Inc (4.2%), Merck & Co Inc (4.17%), and Eli Lilly and Co (3.87%) have a slightly smaller but still significant weight. Danaher Corp and Medtronic PLC are also represented in the XLV’s holdings at 3.61% and 3.54%.
|ASML Holding NV||2.2%|
|Roche Holding AG||2.13%|
|LVMH Moet Hennessy Louis Vuitton SE||1.58%|
|Novo Nordisk A/S B||1.09%|
VGK’s Top Holdings are Nestle SA, ASML Holding NV, Roche Holding AG, LVMH Moet Hennessy Louis Vuitton SE, and Novartis AG at 2.82%, 2.2%, 2.13%, 1.58%, and 1.55%.
AstraZeneca PLC (1.27%), SAP SE (1.25%), and Unilever PLC (1.23%) have a slightly smaller but still significant weight. Novo Nordisk A/S B and Siemens AG are also represented in the VGK’s holdings at 1.09% and 0.96%.
The Health Care Select Sector SPDR Fund (XLV) has a R-squared of 58.19 with a Standard Deviation of 12.94 and a Mean Return of 1.27. Its Sharpe Ratio is 1.13 while XLV’s Treynor Ratio is 21.1. Furthermore, the fund has a Beta of 0.7 and a Alpha of 7.75.
The Vanguard FTSE Europe Index Fund ETF Shares (VGK) has a R-squared of 92.76 with a Sharpe Ratio of 0.4 and a Alpha of 0.45. Its Mean Return is 0.61 while VGK’s Beta is 1.06. Furthermore, the fund has a Standard Deviation of 16.65 and a Treynor Ratio of 5.12.
XLV’s Mean Return is 0.66 points higher than that of VGK and its R-squared is 34.57 points lower. With a Standard Deviation of 12.94, XLV is slightly less volatile than VGK. The Alpha and Beta of XLV are 7.30 points higher and 0.36 points lower than VGK’s Alpha and Beta.
XLV had its best year in 2013 with an annual return of 41.24%. XLV’s worst year over the past decade yielded -2.83% and occurred in 2016. In most years the Health Care Select Sector SPDR Fund provided moderate returns such as in 2011, 2020, and 2012 where annual returns amounted to 12.44%, 13.33%, and 17.56% respectively.
The year 2017 was the strongest year for VGK, returning 27.06% on an annual basis. The poorest year for VGK in the last ten years was 2018, with a yield of -14.79%. Most years the Vanguard FTSE Europe Index Fund ETF Shares has given investors modest returns, such as in 2016, 2010, and 2020, when gains were -0.59%, 5.01%, and 6.5% respectively.
|Fund||Initial Balance||Final Balance||CAGR|
A $10,000 investment in XLV would have resulted in a final balance of $44,147. This is a profit of $34,147 over 11 years and amounts to a compound annual growth rate (CAGR) of 15.02%.
With a $10,000 investment in VGK, the end total would have been $18,350. This equates to a $8,350 profit over 11 years and a compound annual growth rate (CAGR) of 6.68%.
XLV’s CAGR is 8.35 percentage points higher than that of VGK and as a result, would have yielded $25,797 more on a $10,000 investment. Thus, XLV outperformed VGK by 8.35% annually.
Over the past years, I have discovered several tools and products that have helped me tremendously on my path to financial freedom:
P.S.: The links below are affiliate links, which means I receive a small commission at no extra cost to you when you sign up for one of the services. Thank you for your support!
1)Personal Capital is simply the best tool out there to track your net worth and plan for financial freedom. Just their retirement planner alone has become an invaluable tool to keep myself on track financially. Try it out, it's free!
2) Take a look at M1 Finance, my favorite broker. I love how easy it is to invest and maintain my portfolio with them. I can set up automatic transfers, rebalance my portfolio with one click and even borrow up to 35% of my assets at super low interest rates!
3) Fundrise is by far the best way I've found to invest in Real Estate. You can diversify your portfolio by investing in their eREITs or even allocate capital to individual properties (without the hassle of managing tenants!).
4) Groundfloor is another great way to get exposure to the real estate sector by investing in short-term, high-yield real estate debt. Current returns are >10% and you can get started with just $10.
5) If you are interested in startup investing, check out Mainvest. I've started allocating a small amount of assets to invest in and support small businesses. Return targets are between 10-25% and you can start with just $100!
To see all of my most up-to-date recommendations, check out the Recommended Tools section.